A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in United Therapeutics Corp stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 9,346 shares of UTHR stock, worth $3.37 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,346
Holding current value
$3.37 Million
% of portfolio
0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$311.04 - $363.55 $2.91 Million - $3.4 Million
9,346 New
9,346 $3.35 Million
Q4 2023

Feb 14, 2024

BUY
$214.88 - $256.94 $4.32 Million - $5.16 Million
20,084 New
20,084 $4.42 Million
Q2 2022

Aug 15, 2022

BUY
$174.81 - $241.14 $571,978 - $789,010
3,272 New
3,272 $771,000
Q3 2020

Nov 16, 2020

SELL
$99.9 - $121.13 $566,632 - $687,049
-5,672 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$92.74 - $125.82 $526,021 - $713,651
5,672 New
5,672 $686,000
Q1 2020

May 15, 2020

SELL
$79.39 - $115.35 $2.87 Million - $4.17 Million
-36,171 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$78.31 - $95.34 $1.7 Million - $2.06 Million
21,657 Added 149.21%
36,171 $3.19 Million
Q3 2019

Nov 14, 2019

SELL
$74.85 - $85.99 $2.95 Million - $3.39 Million
-39,426 Reduced 73.09%
14,514 $1.16 Million
Q2 2019

Aug 14, 2019

BUY
$76.06 - $120.81 $4.1 Million - $6.52 Million
53,940 New
53,940 $4.21 Million
Q1 2019

May 15, 2019

SELL
$107.15 - $126.84 $826,983 - $978,951
-7,718 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$101.4 - $128.73 $771,045 - $978,862
-7,604 Reduced 49.63%
7,718 $840,000
Q3 2018

Nov 14, 2018

BUY
$113.81 - $129.46 $525,346 - $597,587
4,616 Added 43.12%
15,322 $1.96 Million
Q2 2018

Aug 14, 2018

BUY
$101.14 - $118.31 $1.08 Million - $1.27 Million
10,706 New
10,706 $1.21 Million
Q1 2018

May 15, 2018

SELL
$107.21 - $151.94 $437,952 - $620,674
-4,085 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$118.58 - $151.28 $437,797 - $558,525
-3,692 Reduced 47.47%
4,085 $604,000
Q3 2017

Nov 14, 2017

BUY
$114.6 - $136.81 $891,244 - $1.06 Million
7,777
7,777 $911,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.